Rheumatoid Arthritis: 3 New Things

Nov 05, 2018

What’s new: biologic tapering, high-dose influenza vaccine, real-time patient input.

References1. Dierckx S, Lauwerys BR, Sokolova T, et al. Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost effective in daily clinical practice: DATA from the Brussels UCL RA Cohort. [abstract]. Arthritis Rheumatol. 2018;70(suppl 10). Accessed November 2, 2018.2. Colmegna I, Useche M, Rodriguez K, et al. Efficacy of high-dose versus standard-dose influenza vaccine in seropositive rheumatoid arthritis patients. [abstract]. Arthritis Rheumatol. 2018;70(suppl 10). Accessed November 2, 2018.3. Forman M, Leatherwood C, Xu C, et al. Implementation of a treat-to-target quality improvement program for rheumatoid arthritis management using real-time patient reported outcome measures [abstract]. Arthritis Rheumatol. 2018;70(suppl 10). Accessed November 2, 2018.